(TPG) TPG - Overview
Stock: Private Equity, Real Estate, Credit, Hedge Funds, Advisory
| Risk 5d forecast | |
|---|---|
| Volatility | 53.0% |
| Relative Tail Risk | -1.66% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.39 |
| Alpha | -42.33 |
| Character TTM | |
|---|---|
| Beta | 1.609 |
| Beta Downside | 1.652 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.83% |
| CAGR/Max DD | 0.37 |
EPS (Earnings per Share)
Revenue
Primary Risks
P/E ratio: 578.7
Description: TPG TPG February 13, 2026
TPG Inc. (NASDAQ:TPG) is a global alternative-asset manager that provides investment-management, advisory, debt- and equity-placement, and capital-structuring services to its own funds, limited partners, separately managed accounts and other clients. Founded in 1992 and headquartered in Fort Worth, Texas, the firm invests across private-equity, real-estate, hedge-fund and credit strategies.
**Key recent metrics (as of the latest FY-2024 filing):** - Assets under management (AUM) reached approximately **$136 billion**, up ~5 % YoY, driven by strong capital commitments in its private-equity and credit platforms. - FY-2024 revenue was **$1.92 billion**, with a net income of **$210 million**, reflecting higher fee income but offset by increased investment-level expenses. - The firm’s **operating margin** stood at **13.5 %**, consistent with the asset-management sub-industry average of 12-14 %.
**Sector drivers influencing TPG’s outlook:** - **Private-equity fundraising** remains robust; U.S. PE fund commitments hit a 12-month high of $250 billion in Q3 2024, supporting fee-generation for managers like TPG. - **Interest-rate volatility** poses a dual effect: higher borrowing costs compress leveraged-buyout returns, yet elevated rates improve yields on TPG’s credit and debt-capital strategies. - **Macro-economic uncertainty** (e.g., slower GDP growth forecasts for 2025) may pressure exit multiples, making TPG’s diversified multi-asset approach a defensive hedge.
Given these dynamics, a deeper dive into TPG’s fee-structure trends and credit-portfolio performance could clarify its resilience; you might find **ValueRay’s analytical tools** useful for that next step.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 166.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.05 > 1.0 |
| NWC/Revenue: -121.3% < 20% (prev 48.90%; Δ -170.2% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.08b > Net Income 166.7m |
| Net Debt (896.4m) to EBITDA (802.5m): 1.12 < 3 |
| Current Ratio: 0.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (152.8m) vs 12m ago -58.13% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 31.38% > 50% (prev 24.90%; Δ 6.48% > 0%) |
| Interest Coverage Ratio: 8.06 > 6 (EBITDA TTM 802.5m / Interest Expense TTM 81.7m) |
Altman Z'' -1.79
| A: -0.34 (Total Current Assets 826.1m - Total Current Liabilities 5.40b) / Total Assets 13.49b |
| B: -0.02 (Retained Earnings -294.4m / Total Assets 13.49b) |
| C: 0.05 (EBIT TTM 658.3m / Avg Total Assets 12.01b) |
| D: 0.13 (Book Value of Equity 1.19b / Total Liabilities 9.36b) |
| Altman-Z'' Score: -1.79 = D |
Beneish M
| DSRI: none (Receivables none/447.0m, Revenue 3.77b/2.62b) |
| GMI: 1.00 (GM 96.74% / 96.66%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.44 (Revenue 3.77b / 2.62b) |
| TATA: -0.07 (NI 166.7m - CFO 1.08b) / TA 13.49b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of TPG shares?
Over the past week, the price has changed by -8.98%, over one month by -28.26%, over three months by -18.24% and over the past year by -20.25%.
Is TPG a buy, sell or hold?
- StrongBuy: 4
- Buy: 1
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TPG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 65.6 | 47.4% |
| Analysts Target Price | 65.6 | 47.4% |
TPG Fundamental Data Overview February 21, 2026
P/E Forward = 20.9644
P/S = 3.6592
P/B = 6.6315
Revenue TTM = 3.77b USD
EBIT TTM = 658.3m USD
EBITDA TTM = 802.5m USD
Long Term Debt = unknown (none)
Short Term Debt = 16.2m USD (from shortTermDebt, two quarters ago)
Debt = 1.72b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 896.4m USD (from netDebt column, last quarter)
Enterprise Value = 22.78b USD (21.88b + Debt 1.72b - CCE 826.1m)
Interest Coverage Ratio = 8.06 (Ebit TTM 658.3m / Interest Expense TTM 81.7m)
EV/FCF = 21.55x (Enterprise Value 22.78b / FCF TTM 1.06b)
FCF Yield = 4.64% (FCF TTM 1.06b / Enterprise Value 22.78b)
FCF Margin = 28.02% (FCF TTM 1.06b / Revenue TTM 3.77b)
Net Margin = 4.42% (Net Income TTM 166.7m / Revenue TTM 3.77b)
Gross Margin = unknown ((Revenue TTM 3.77b - Cost of Revenue TTM 123.0m) / Revenue TTM)
Tobins Q-Ratio = 1.69 (Enterprise Value 22.78b / Total Assets 13.49b)
Interest Expense / Debt = 1.88% (Interest Expense 32.3m / Debt 1.72b)
Taxrate = 7.38% (22.5m / 304.9m)
NOPAT = 609.7m (EBIT 658.3m * (1 - 7.38%))
Current Ratio = 0.15 (Total Current Assets 826.1m / Total Current Liabilities 5.40b)
Debt / Equity = 1.45 (Debt 1.72b / totalStockholderEquity, last quarter 1.19b)
Debt / EBITDA = 1.12 (Net Debt 896.4m / EBITDA 802.5m)
Debt / FCF = 0.85 (Net Debt 896.4m / FCF TTM 1.06b)
Total Stockholder Equity = 1.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.39% (Net Income 166.7m / Total Assets 13.49b)
RoE = 16.10% (Net Income TTM 166.7m / Total Stockholder Equity 1.04b)
RoCE = 8.13% (EBIT 658.3m / Capital Employed (Total Assets 13.49b - Current Liab 5.40b))
RoIC = 23.32% (NOPAT 609.7m / Invested Capital 2.61b)
WACC = 11.11% (E(21.88b)/V(23.60b) * Re(11.85%) + D(1.72b)/V(23.60b) * Rd(1.88%) * (1-Tc(0.07)))
Discount Rate = 11.85% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -33.34%
[DCF Debug] Terminal Value 57.98% ; FCFF base≈835.6m ; Y1≈555.3m ; Y5≈259.7m
Fair Price DCF = 16.50 (EV 3.31b - Net Debt 896.4m = Equity 2.42b / Shares 146.5m; r=11.11% [WACC]; 5y FCF grow -39.11% → 2.90% )
EPS Correlation: 19.25 | EPS CAGR: -14.30% | SUE: -4.0 | # QB: 0
Revenue Correlation: 41.41 | Revenue CAGR: 8.17% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.65 | Chg30d=+0.010 | Revisions Net=-1 | Analysts=10
EPS next Year (2026-12-31): EPS=2.88 | Chg30d=-0.060 | Revisions Net=+0 | Growth EPS=+114.9% | Growth Revenue=+21.6%